000 | 01879 a2200553 4500 | ||
---|---|---|---|
005 | 20250516171001.0 | ||
264 | 0 | _c20131216 | |
008 | 201312s 0 0 eng d | ||
022 | _a1479-683X | ||
024 | 7 |
_a10.1530/EJE-13-0419 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSarfati, Julie | |
245 | 0 | 0 |
_aGreater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients. _h[electronic resource] |
260 |
_bEuropean journal of endocrinology _cDec 2013 |
||
300 |
_a805-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAfrica, Northern |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArabs _xgenetics |
650 | 0 | 4 | _aEurope |
650 | 0 | 4 | _aExons |
650 | 0 | 4 |
_aExtracellular Matrix Proteins _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibroblast Growth Factor 8 _xgenetics |
650 | 0 | 4 |
_aGastrointestinal Hormones _xgenetics |
650 | 0 | 4 | _aGene Frequency |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIntrons |
650 | 0 | 4 |
_aKallmann Syndrome _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aNerve Tissue Proteins _xgenetics |
650 | 0 | 4 |
_aNeuropeptides _xgenetics |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 |
_aReceptor, Fibroblast Growth Factor, Type 1 _xgenetics |
650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xgenetics |
650 | 0 | 4 |
_aReceptors, Peptide _xgenetics |
650 | 0 | 4 | _aSequence Analysis, DNA |
650 | 0 | 4 |
_aWhite People _xgenetics |
700 | 1 | _aFouveaut, Corinne | |
700 | 1 | _aLeroy, Chrystel | |
700 | 1 | _aJeanpierre, Marc | |
700 | 1 | _aHardelin, Jean-Pierre | |
700 | 1 | _aDodé, Catherine | |
773 | 0 |
_tEuropean journal of endocrinology _gvol. 169 _gno. 6 _gp. 805-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1530/EJE-13-0419 _zAvailable from publisher's website |
999 |
_c23083386 _d23083386 |